Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.4.2 was added and the previous revision v3.4.1 was removed in the page history. This is a metadata update to the history log and does not affect study data or page functionality.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision metadata updated: 'Revision: v3.4.1' was added and 'Revision: v3.4.0' was removed. This change affects only page revision information and does not modify study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page adds a 'Show glossary' option and explains color-coded highlights (green for additions, red for deletions) to reflect changes in the study record. The Revision note updates from v3.3.4 to v3.4.0 and 'No FEAR Act data' wording is adjusted; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedA new revision entry, v3.3.4, was added to the Record History, replacing v3.3.3; this appears to be a minor administrative update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the page history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 entry were removed from the footer.SummaryDifference0.1%

- Check70 days agoChange DetectedTwo new history entries were added (Study Status on 2025-12-15 and version 33 on 2025-12-10), and the 2025-07-30 entry was removed.SummaryDifference0.3%

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.